Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 241-243

  Ishii, Takanori ^a   Hosoya, Mitsuaki ^a   Mori, Shuichi ^a   Shigeta, Shiro ^a   Suzuki, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG BRAIN LEVEL; HAMSTER; NONHUMAN; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0030050737     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.241     Document Type: Article

References (14)

1. Banks, G., and H. Fernandez. 1984. Clinical use of ribavirin in measles: a summarized review, p. 203-209. In R. A Smith, V Knight, and J A D. Smith (ed), Clinical applications of ribavirin. Academic Press, Inc., New York.
2. Crumpacker, C., G. Bubley, D. Lucey, S. Hussey, and J. Conner. 1986. Ribavirin enters cerebrospinal fluid. Lancet ii:45-46.
3. De Clercq, E., M. Cools, J. Balzarini, R. Snoeck, G. Andrei, M. Hosoya, S. Shigeta, T. Ueda, N. Minakawa, and A. Matsuda. 1991. Antiviral activities of 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide and related compounds Antimicrob. Agents Chemother. 35:679-684
4. Fukuyama, Y., K. Nihei, S. Matsumoto, J. Tateishi, and A. Sakuma, 1987 Clinical effects of MND-19 (mosiplex) on subacute sclerosing panencephalitis. Brain Dev 9:270-283.
5. Gilbert, B. E., P. R. Wyde, S. Z. Wilson, and R. K. Robins. 1991. Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus. Antimicrob. Agents Chemother 35:1448-1453.
6. Honda, Y., M. Hosoja, T. Ishii, S. Shigeta, and H. Suzuki. 1994. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters Antimicrob. Agents Chemother. 38:653-655
7. Hosoya, M., S. Shigeta, T. Ishii, H. Suzuki, and E. De Clercq. 1993 Comparative inhibitory effects of various nucleoside and nonnucleoside analogues on replication of influenza virus types A and B in vitro and in ovo. J. Infect. Dis. 168:641-646.
8. Hosoya, M., S. Shigeta, K. Nakamura, and E. De Clercq. 1989. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antiviral Res, 12:87-98.
9. Jabour, J. T., J. H. Gracia, H. Lemme, J. Regland, D. A. Duenas, and J. L. Sever. 1969. Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases. JAMA 207:2248-2254.
10. Jones, C. E., P. R. Dyken, P. R. Huttenlocher, J. T. Jabbour, and K. W. Maxwell. 1982. Inosiplex therapy in subacute sclerosing panencephalitis, Lancet i:1034-1037.
11. Kuroki, S., T. Tsutsui, M. Yoshioka, H. Mizue, M. Kita, and T. Kishida. 1989. The effect of interferon on subacute sclerosing panencephalitis Brain Dev 11:65-69.
12. Ogle, J. W., P. Toltzis, W. D. Parker, N. Alvarez, K. McIntosh, M. Levin, and B. A. Lauer. 1989 Oral ribavirin therapy for subacute sclerosing panencephalitis. J. Infect Dis. 159:748-750.
13. Panitch, H. S., J. G. Plascencia, F. H. Norris, K. Cantell, and R. A. Smith. 1986. Subacute sclerosing panencephalitis. remission after treatment with intravcntricular interferon, Neurology 36:562-566.
14. Sugita, T., K. Shiraki, S. Ueda, N. Iwa, H. Shoji, M. Ayata, and S. Kato. 1984. Induction of acute myoclonic encephalopathy in hamsters by subacute sclerosing panencephalitis virus. J. Infect. Dis. 150:340-347.